Trial
NCT03060356
Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Malignant Melanoma
Intervention
T cells modified with RNA anti -cMET CAR
Why stopped
Halt in funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-22